High mortality and coinfection in a prospective cohort of human immunodeficiency virus/acquired immune deficiency syndrome patients with histoplasmosis in Guatemala

Histoplasmosis is one of the most common and deadly opportunistic infections among persons living with human immunodeficiency virus (HIV)/acquired immune deficiency syndrome in Latin America, but due to limited diagnostic capacity in this region, few data on the burden and clinical characteristics of this disease exist. Between 2005 and 2009, we enrolled patients 18 years of age with suspected histoplasmosis at a hospital-based HIV clinic in Guatemala City. A case of suspected histoplasmosis was defined as a person presenting with at least three of five clinical or radiologic criteria. A confirmed case of histoplasmosis was defined as a person with a positive culture or urine antigen test for Histoplasma capsulatum. Demographic and clinical data were also collected and analyzed. Of 263 enrolled as suspected cases of histoplasmosis, 101 (38.4%) were confirmed cases. Median time to diagnosis was 15 days after presentation (interquartile range [IQR] = 5-23). Crude overall mortality was 43.6%; median survival time was 19 days (IQR = 4-69). Mycobacterial infection was diagnosed in 70 (26.6%) cases; 26 (25.7%) histoplasmosis cases were coinfected with mycobacteria. High mortality and short survival time after initial symptoms were observed in patients with histoplasmosis. Mycobacterial coinfection diagnoses were frequent, highlighting the importance of pursuing diagnoses for both diseases. and copy; 2017 by The American Society of Tropical Medicine and Hygiene.

• Fecha de publicación: 2017
• Institución: Universidad del Rosario
• Repositorio: Repositorio EdocUR - U. Rosario
• Idioma: eng
• OAI Identifier: oai:repository.urosario.edu.co:10336/24207
• Acceso en línea: https://doi.org/10.4269/ajtmh.16-0009; https://repository.urosario.edu.co/handle/10336/24207
• Palabra clave: Amphotericin B; Antiretrovirus agent; Fluconazole; Itraconazole; Acquired immune deficiency syndrome; Ajellomyces capsulatus; Antifungal therapy; Antiretroviral therapy; Article; Clinical feature; Cohort analysis; Guatemala; Histoplasmosis; Human; Human immunodeficiency virus infection; Infection sensitivity; Median survival time; Medical history; Mixed infection; Mortality; Mycobacteriosis; Prospective study; Acquired immune deficiency syndrome; Adult; Aged; AIDS related complex; Cause of death; Complication; Female; Histoplasma; Histoplasmosis; Human immunodeficiency virus infection; Isolation and purification; Male; Middle aged; Mixed infection; Mortality; Survival; Very elderly; Young adult; Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; AIDS-Related Opportunistic Infections; Cause of Death; Cohort Studies; Coinfection; Female; Guatemala; Histoplasma; Histoplasmosis; HIV Infections; Humans; Male; Middle Aged; Mortality; Prospective Studies; Survival; Young Adult
• License: Abierto (Texto Completo)